MEDICAL CHANNEL ASIA

PUBLIC PORTAL

PUBLIC PORTAL

MEDICALLY REVIEWED

Romosozumab (Evenity) for the Treatment of Osteoporosis

Evenity Romosozumab

In May 2021, the Health Sciences Authority (HSA) approved the use of Romosozumab (Evenity), a novel biologic, for the treatment osteoporosis in postmenopausal women at high risk of fractures. Fragility fractures are common amongst postmenopausal . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

covid-19 Self-Test Kits

COVID-19 Self-Test Kits

The Singapore government has recently announced that COVID-19 self-test kits are now available to the general public for purchase at retail pharmacies. This mode of

Read More »

People also read:

COPD
An Overview on COPD

Professor Paul Jones shares his years-long experience treating patients with COPD. Get to know its symptoms, causes and how it affects Asians

Read More »